Clinical trials
Thrombosis clinical trials
Below are recruiting thrombosis clinical trials, each written for real people, not researchers. We’re tracking 180 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06820515Recruiting
Blood disorder patient registry for all ages
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
Hickory, North CarolinaAges Any age - NCT06842446Recruiting
Fast detection of blood clots using machine learning
This trial tests whether a machine learning algorithm can quickly detect deep vein thrombosis (blood clots) in people coming to the emergency room. It could help speed up diagnosis and treatment.
SarpsborgAges 18 years+ - NCT06886516RecruitingEarly Phase 1
Blood thinner study for cancer patients with low platelets
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
Boston, MassachusettsAges 18 years+ - NCT06909240Recruiting
Walking training after first leg blood clot: a study
This study tests whether a progressive walking program helps people recover better after their first leg blood clot (DVT). You would be part of a walking training group and researchers will see if it improves walking ability and leg symptoms.
Hvidovre, Capital RegionAges 18 years+ - NCT06947707Recruiting
Blood thinners for brain blood clot in Chinese patients
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Beijing, Beijing MunicipalityAges 18–80 - NCT06960954Recruiting
Testing a blood marker for liver cancer blood clots
This study looks at whether a substance in the blood called PIVKA-II can predict blood clots in the main vein of the liver (portal vein) in people with liver cancer. Participating could help doctors better identify who might develop this complication.
Tanta, GharbyeaAges 18 years+ - NCT07083609Recruiting
Blood thinners for brain vein clots in Vietnam
This trial tests a type of blood thinner called DOACs for people with a clot in a brain vein (cerebral venous thrombosis). DOACs may be an easier treatment option, and this study looks at how well they work in adults in Vietnam.
HanoiAges 18 years+ - NCT07210671Recruiting
Study on treating vein clots in cancer patients
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
AmiensAges 18 years+ - NCT07352358RecruitingPhase 4
Blood thinners plus batroxobin for brain vein clots
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
Beijing, Beijing MunicipalityAges 18–80 - NCT07372170Recruiting
Blood thinners for preventing another clot in low-risk APS
This study looks at how well blood thinners prevent blood clots from coming back in people with antiphospholipid syndrome (APS) who are considered low risk. It compares two types of medicines: direct oral anticoagulants (DOACs) and vitamin K antagonists.
Madrid, MadridAges 18 years+ - NCT07461532Recruiting
Apixaban for late portal vein clot after spleen surgery
This trial is testing whether a blood thinner called apixaban can treat a blood clot in the main vein to the liver (portal vein) that appeared more than a year after spleen surgery in people with cirrhosis. It compares apixaban to a low-dose aspirin to see if one works better with fewer side effects.
Yangzhou, JiangsuAges 18 years+ - NCT07461545Recruiting
Apixaban for late portal vein clot after spleen surgery
This trial tests if apixaban, a blood thinner, is more effective than aspirin at treating blood clots in the portal vein that form more than a year after laparoscopic spleen removal in people with cirrhosis and an enlarged spleen.
Yangzhou, JiangsuAges 18 years+ - NCT07523880Recruiting
Blood Markers Study for Heart Disease and Blood Clot Risk
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
Zhengzhou, HenanAges 18 years+ - NCT07622212Recruiting
Comparing devices to clear leg blood clots quickly
This trial compares different mechanical devices used to remove recent blood clots from the deep veins in your leg (iliac and femoral veins). The goal is to restore blood flow and prevent long-term complications like chronic pain and swelling.
ShanghaiAges 18–85 - NCT07665320Recruiting
Monitoring DVT treatment with a new skin sensor
This study tests a new, non-invasive skin sensor that uses electrical currents to see how well clot-busting medication is working in people with deep vein thrombosis (a blood clot in the leg). The goal is to make monitoring easier and more comfortable.
TampereAges 18 years+ - NCT06370702Enrolling by invitation
Can hand grip exercises prevent blood clots from PICC lines?
This study tests if simple hand grip exercises can help prevent blood clots in the arm for people who just got a PICC line. If you are at least 18 and can do the exercises, you may be able to join.
Cincinnati, OhioAges 18 years+ - NCT06166576RecruitingPhase 2
Radioembolization for Liver Cancer with Vein Involvement
This trial tests a targeted radiation treatment (radioembolization) for liver cancer that has grown into the main vein (portal vein) but is still limited to one lobe of the liver. It is for people who have not received any prior cancer treatment and whose liver function is still fairly good.
Ilsan, Gyeonggi-doAges 18 years+ - NCT07762222Recruiting
Iliac vein stenting for chronic post-thrombotic venous ulcers
This trial tests whether placing a stent (a small mesh tube) in the iliac vein can help heal chronic leg ulcers caused by prior blood clots. The goal is to improve blood flow and reduce symptoms.
CairoAges 18–70 - NCT07749820Recruiting
Clot removal device for leg vein blood clots
This study tests a device that removes blood clots from the deep veins of your leg. It's designed to help people with recent or slightly older clots in the thigh or pelvic area, aiming to reduce symptoms and prevent complications.
ShanghaiAges 18 years+ - NCT06329921Enrolling by invitation
Heparin monitoring study at Vanderbilt
This study looks at how well a blood test (PTT) monitors the blood thinner heparin in hospital patients. If you are getting heparin through an IV, this research may help improve how your treatment is managed.
Nashville, TennesseeAges 18 years+ - NCT03797495Recruiting
Study for people with low plasminogen or their close family
This study looks at people diagnosed with type 1 plasminogen deficiency (a condition with low plasminogen levels) and can also include their first-degree family members. It may help researchers learn more about the condition and how to monitor it over time by collecting blood and genetic information.
Birmingham, AlabamaAges Any age - NCT06198816Recruiting
Ultrasound and balloon treatment for old leg clots
This study tests a new way to treat long-standing blood clots in the leg using ultrasound waves and a balloon procedure. It aims to improve blood flow and reduce symptoms like swelling and pain for people who haven't gotten better with standard treatments.
Milan, ItalyAges 18–75 - NCT05588284Enrolling by invitation
Check whether a special treatment protects vein valves after clot
This study enrolls people with an acute blood clot in the thigh or pelvis veins to see how well a procedure called PCDT (using a Zelante device) preserves the function of vein valves. It may help reduce complications like ongoing vein problems after a clot.
Chuzhou, AnhuiAges 18–80 - NCT05041569Recruiting
MRI study of brain vein damage and swelling patterns
This pilot study uses an MRI scan that involves an injected contrast to look at how brain blood-flow pathways are being blocked or narrowed. The goal is to better understand the kind of damage caused by these vein problems, which may help doctors monitor and plan care.
Paris, ParisAges 18 years+
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis?
- Yes. Clin2 currently lists 180 recruiting thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.